Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Blum

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Environmental Health Perspectives|February 1, 1996
A human in vivo model for the determination of lead bioavailability using stable isotope dilutionJ H Graziano, C B Blum, N J Lolacono, et al.
The New England Journal of Medicine|October 26, 1978
Metabolism of high-density lipoprotein apolipoproteins in Tangier diseaseE J Schaefer, C B Blum, R I Levy, et al.
The New England Journal of Medicine|December 11, 1986
Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarctionR A Hegele, L S Huang, P N Herbert, et al.
Circulation|January 1, 1992
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarctionJ E Buring, G T O'Connor, S Z Goldhaber, et al.
Journal of Lipid Research|June 1, 1986
Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotypeR H Palmer, A V Nichols, R B Dell, et al.
Journal of Lipid Research|July 1, 1989
Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteinsC L Bisgaier, M V Siebenkas, C B Hesler, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Environmental Health Perspectives|February 1, 1996
A human in vivo model for the determination of lead bioavailability using stable isotope dilutionJ H Graziano, C B Blum, N J Lolacono, et al.
The New England Journal of Medicine|October 26, 1978
Metabolism of high-density lipoprotein apolipoproteins in Tangier diseaseE J Schaefer, C B Blum, R I Levy, et al.
The New England Journal of Medicine|December 11, 1986
Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarctionR A Hegele, L S Huang, P N Herbert, et al.
Circulation|January 1, 1992
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarctionJ E Buring, G T O'Connor, S Z Goldhaber, et al.
Journal of Lipid Research|June 1, 1986
Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotypeR H Palmer, A V Nichols, R B Dell, et al.
Journal of Lipid Research|July 1, 1989
Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteinsC L Bisgaier, M V Siebenkas, C B Hesler, et al.
Pageof 4